The Age
·general
·5 hours ago
Proteomics diagnostic tests shift from lab coats to commercial launch
Proteomics International Laboratories announced a shift to commercial operations this week, unveiling a three-year plan to scale its diagnostics business. With a focus on strategic partnerships, the company aims to launch tests like PromarkerD, which predicts diabetes-related kidney disease, tapping into a market of 390,000 annual tests in the United States.
Summary by Glance · The Age
Next
Loving doing this? 🎉
Take it further — get the full app and never miss a moment of what's happening in Australia.
Breaking news alerts
Instant lock-screen notifications the moment big stories break across Australia.
Australian news & events
Politics, sport, weather, local events — all in one swipeable feed, updated around the clock.
Stay ahead of the news cycle
30-second summaries so you're always informed, even on your busiest days.
Loading article…
This publisher's site can't be shown here due to their security settings.
Open full article →No source link available for this article.
✨
Ask AI